Qube Research & Technologies (QRT)
BNTC icon

Qube Research & Technologies (QRT)’s Benitec Biopharma BNTC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,003
Closed -$247K – 3566
2025
Q1 		$247K Sell
19,003
-1,893
-9% -$22.9K ﹤0.01% 2799
2024
Q4 		$264K Buy
+20,896
New +$226K ﹤0.01% 2760

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BNTC Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Benitec Biopharma (BNTC) in Q2 2025, closing a stake of 19,003 shares — an estimated $247K sold.

Qube Research & Technologies (QRT) first reported a position in BNTC in Q4 2024 and held it in 2 quarters. The position peaked at $264K in Q4 2024. 57 funds tracked by Wall St. Rank hold BNTC as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Benitec Biopharma position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 19,003 Benitec Biopharma shares in Q2 2025, an estimated $247K.
  • Qube Research & Technologies (QRT) first reported a position in Benitec Biopharma in Q4 2024 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Benitec Biopharma position peaked at $264K in Q4 2024.
  • 57 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.